A Retrospective Study to Assess the Safety and Effectiveness of Tofacitinib as Monotherapy or in Combination with Biologic Therapy in Patients with Crohn's Disease
Latest Information Update: 10 Jul 2020
At a glance
- Drugs Tofacitinib (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- 10 Jul 2020 New trial record
- 19 May 2020 Results published in Gasteroenterology in conjunction with Digestive Disease Week 2020.